Skip to content

Clinical trials

Completed Lung Diseases, Interstitial trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Completed Country / region: United Kingdom Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20102
20121
20141
20161
20177
20182
20193
20201
20213
20225
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Royal Brompton & Harefield NHS Foundation Trust4
Imperial College London2
Insmed Incorporated2
Kingston University2
Actelion1
Bristol-Myers Squibb1
GlaxoSmithKline1
Heart of England NHS Trust1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial32
Idiopathic Pulmonary Fibrosis6
Pulmonary Disease, Chronic Obstructive6
Asthma5
Lung Neoplasms3
Sarcoidosis3
Sarcoidosis, Pulmonary3
Bronchiectasis2
Cystic Fibrosis2
Disease2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.